Company intelligence / Profile preview

Sundance Pharmaceuticals

Greenbrae, California, United Statessundancepharma.com ↗

Ownership: Private
Development stage: Other

Overview

Sundance Pharmaceuticals is developing cannabis-based pharmaceutical drugs targeting major illnesses. The company is preparing for clinical trials in the U.S. and Canada for several indications including COVID‑19, rheumatoid arthritis, acute pain, opioid dependence, traumatic brain injury/concussion, and supportive care in oncology. Their approach includes both prescription pharmaceuticals intended to be covered by insurance as well as self-care natural products where legal.

Therapeutic areas: NeurologyPsychiatryInfectious DiseasesOncologyImmunology
Modalities: Small moleculeCannabis-derived drugCombination therapy (pharmaceutical + cannabis-derived)
Industry: Biotech

Beyond the preview

Go deeper on Sundance Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sundance Pharmaceuticals.

Explore the full profile